135 related articles for article (PubMed ID: 37232564)
1. The Association Between Taxane Use and Lacrimal Disorders.
McGwin G; Contorno T; Vicinanzo MG; Owsley C
Curr Eye Res; 2023 Sep; 48(9):873-877. PubMed ID: 37232564
[TBL] [Abstract][Full Text] [Related]
2. Risk of Ocular Adverse Events With Taxane-Based Chemotherapy.
Sodhi M; Yeung SN; Maberley D; Mikelberg F; Etminan M
JAMA Ophthalmol; 2022 Sep; 140(9):880-884. PubMed ID: 35951320
[TBL] [Abstract][Full Text] [Related]
3. Data mining for signal detection of adverse events for taxanes based on the food and drug administration adverse drug events reporting system database.
Wang LY; Liao LF; Lei CL; Wu Q; Guo YJ; Li Y
Expert Opin Drug Saf; 2023; 22(9):833-839. PubMed ID: 37055919
[TBL] [Abstract][Full Text] [Related]
4. Epiphora in lung cancer patients receiving docetaxel: a case series.
Yamagishi T; Ochi N; Yamane H; Hasebe S; Takigawa N
BMC Res Notes; 2014 May; 7():322. PubMed ID: 24886618
[TBL] [Abstract][Full Text] [Related]
5. Blockage of the lacrimal drainage apparatus as a side effect of docetaxel therapy.
Esmaeli B; Hidaji L; Adinin RB; Faustina M; Coats C; Arbuckle R; Rivera E; Valero V; Tu SM; Ahmadi MA
Cancer; 2003 Aug; 98(3):504-7. PubMed ID: 12879466
[TBL] [Abstract][Full Text] [Related]
6. Canalicular stenosis secondary to weekly docetaxel: a potentially preventable side effect.
Esmaeli B; Hortobagyi G; Esteva F; Valero V; Ahmadi MA; Booser D; Ibrahim N; Delpassand E; Arbuckle R
Ann Oncol; 2002 Feb; 13(2):218-21. PubMed ID: 11885997
[TBL] [Abstract][Full Text] [Related]
7. Docetaxel-induced histologic changes in the lacrimal sac and the nasal mucosa.
Esmaeli B; Burnstine MA; Ahmadi MA; Prieto VG
Ophthalmic Plast Reconstr Surg; 2003 Jul; 19(4):305-8. PubMed ID: 12878879
[TBL] [Abstract][Full Text] [Related]
8. A double-blind randomized phase II study on the efficacy of topical eye treatment in the prevention of docetaxel-induced dacryostenosis.
Leyssens B; Wildiers H; Lobelle JP; Gillis A; Paridaens R; Mombaerts I
Ann Oncol; 2010 Feb; 21(2):419-423. PubMed ID: 19622592
[TBL] [Abstract][Full Text] [Related]
9. Canalicular stenosis secondary to docetaxel (taxotere): a newly recognized side effect.
Esmaeli B; Valero V; Ahmadi MA; Booser D
Ophthalmology; 2001 May; 108(5):994-5. PubMed ID: 11320034
[TBL] [Abstract][Full Text] [Related]
10. Management of excessive tearing as a side effect of docetaxel.
Esmaeli B
Clin Breast Cancer; 2005 Feb; 5(6):455-7. PubMed ID: 15748466
[TBL] [Abstract][Full Text] [Related]
11. Taxanes for the adjuvant treatment of early breast cancer: systematic review and economic evaluation.
Ward S; Simpson E; Davis S; Hind D; Rees A; Wilkinson A
Health Technol Assess; 2007 Oct; 11(40):1-144. PubMed ID: 17903394
[TBL] [Abstract][Full Text] [Related]
12. Epiphora induced by intermittent docetaxel (taxotere) in patients with non-small cell lung cancer.
Spell DW; Estephan FF; Lin JT; Jones DV
Cancer Invest; 2003; 21(4):550-2. PubMed ID: 14533445
[No Abstract] [Full Text] [Related]
13. Assessing taxane-associated adverse events using the FDA adverse event reporting system database.
Lao DH; Chen Y; Fan J; Zhang JZ
Chin Med J (Engl); 2021 Jun; 134(12):1471-1476. PubMed ID: 34074841
[TBL] [Abstract][Full Text] [Related]
14. Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast Cancer.
Mo H; Yan X; Zhao F; Teng Y; Sun X; Lv Z; Cao M; Zhao J; Song G; Pan B; Li H; Zhai J; Xu B; Ma F
JAMA Netw Open; 2022 Nov; 5(11):e2239788. PubMed ID: 36322088
[TBL] [Abstract][Full Text] [Related]
15. Canalicular stenosis secondary to weekly versus every-3-weeks docetaxel in patients with metastatic breast cancer.
Esmaeli B; Hortobagyi GN; Esteva FJ; Booser D; Ahmadi MA; Rivera E; Arbuckle R; Delpassand E; Guerra L; Valero V
Ophthalmology; 2002 Jun; 109(6):1188-91. PubMed ID: 12045065
[TBL] [Abstract][Full Text] [Related]
16. Comparison of an AC-taxane versus AC-free regimen and paclitaxel versus docetaxel in patients with lymph node-positive breast cancer: Final results of the National Surgical Adjuvant Study of Breast Cancer 02 trial, a randomized comparative phase 3 study.
Watanabe T; Kuranami M; Inoue K; Masuda N; Aogi K; Ohno S; Iwata H; Mukai H; Uemura Y; Ohashi Y
Cancer; 2017 Mar; 123(5):759-768. PubMed ID: 28081304
[TBL] [Abstract][Full Text] [Related]
17. [A Retrospective Analysis of Epiphora Due to Docetaxel].
Noguchi Y; Kawashima Y; Kawara H; Tokuyama Y; Tamura Y; Uchiyama K; Shimizu Y
Gan To Kagaku Ryoho; 2016 Jun; 43(6):737-41. PubMed ID: 27306811
[TBL] [Abstract][Full Text] [Related]
18. Description of anaphylactic reactions to paclitaxel and docetaxel reported to the FDA, with a focus on the role of premedication.
Raisch DW; Campbell W; Garg V; Qureshi ZP; Bookstaver PB; Norris LB; Bennett CL
Expert Opin Drug Saf; 2011 Jul; 10(4):521-8. PubMed ID: 21595611
[TBL] [Abstract][Full Text] [Related]
19. Ophthalmic adverse effects of taxanes: The Mayo Clinic experience.
Fortes BH; Liou H; Dalvin LA
Eur J Ophthalmol; 2022 Jan; 32(1):602-611. PubMed ID: 33148049
[TBL] [Abstract][Full Text] [Related]
20. Surgical treatment of canalicular stenosis in patients receiving docetaxel weekly.
Ahmadi MA; Esmaeli B
Arch Ophthalmol; 2001 Dec; 119(12):1802-4. PubMed ID: 11735790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
